Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer

NCT03125928 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer

Interventions

DRUG: Atezolizumab
DRUG: Paclitaxel
DRUG: Trastuzumab
DRUG: Pertuzumab

Sponsor

Fox Chase Cancer Center

Collaborators

[object Object]